Dr. Shirish Gadgeel, MD
Claim this profileHenry Ford Hospital
Expert in Lung Cancer
Studies Solid Tumors
19 reported clinical trials
30 drugs studied
About Shirish Gadgeel, MD
Education:
- Received an MD (Doctor of Medicine) from the University of Bombay, India, in 1987.
Experience:
- Serves as a Clinical Professor of Oncology at Wayne State University School of Medicine.
- Holds the position of Chief of Thoracic Oncology at the Henry Ford Cancer Institute.
- Acts as the Director of the Thoracic Oncology Research Program at the Henry Ford Cancer Institute.
Area of expertise
1Lung Cancer
Global LeaderStage IV
HER2 positive
Stage III
2Solid Tumors
Stage IV
Stage III
HER2 positive
Affiliated Hospitals
Clinical Trials Shirish Gadgeel, MD is currently running
Adagrasib Combo Therapy
for Lung Cancer
Study CA239-0010 is an open-label, Phase 2 clinical trial evaluating the clinical efficacy of adagrasib in combination with pembrolizumab and chemotherapy in the first-line setting for patients with advanced NSCLC with TPS ≥ 1%, TPS \<50% and KRAS G12C mutation
Recruiting1 award Phase 24 criteria
LY4066434
for Solid Tumors
The main purpose of the study is to assess whether the study drug, LY4066434, is safe and tolerable when administered to participants with locally advanced or metastatic solid tumors with certain KRAS mutations. LY4066434 will be given alone or in combination with other treatments. The study will have 2 parts: monotherapy dose escalation and dose optimization. The study is expected to last up to approximately 5 years.
Recruiting1 award Phase 14 criteria
More about Shirish Gadgeel, MD
Clinical Trial Related4 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Shirish Gadgeel, MD has experience with
- Pembrolizumab
- Pemetrexed
- Carboplatin
- Avutometinib (VS-6766)
- TPX-0022
- Repotrectinib (TPX-0005)
Breakdown of trials Shirish Gadgeel, MD has run
Lung Cancer
Solid Tumors
Non-Small Cell Lung Cancer
Metastatic Tumor
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Shirish Gadgeel, MD specialize in?
Shirish Gadgeel, MD focuses on Lung Cancer and Solid Tumors. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are HER2 positive.
Is Shirish Gadgeel, MD currently recruiting for clinical trials?
Yes, Shirish Gadgeel, MD is currently recruiting for 9 clinical trials in Detroit Michigan. If you're interested in participating, you should apply.
Are there any treatments that Shirish Gadgeel, MD has studied deeply?
Yes, Shirish Gadgeel, MD has studied treatments such as Pembrolizumab, Pemetrexed, Carboplatin.
What is the best way to schedule an appointment with Shirish Gadgeel, MD?
Apply for one of the trials that Shirish Gadgeel, MD is conducting.
What is the office address of Shirish Gadgeel, MD?
The office of Shirish Gadgeel, MD is located at: Henry Ford Hospital, Detroit, Michigan 48202 United States. This is the address for their practice at the Henry Ford Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.